Categories: Insider Trading News

Tempus AI CEO Eric Lefkofsky sells $7 million in shares


Eric Lefkofsky, CEO and Chairman of Tempus AI, Inc. (NASDAQ:TEM), not too long ago bought shares price roughly $7,045,334, in response to an SEC submitting. The transactions occurred on December 18, 2024, with the sale costs starting from $37.34 to $39.38 per share. The sale comes because the inventory has skilled a major 13% decline over the previous week, in response to InvestingPro information. Following these transactions, Lefkofsky retains important holdings within the firm by way of varied entities, together with Blue Media, LLC and Grey Media, LLC. The gross sales have been made beneath a pre-established buying and selling plan. The $5.2 billion market cap firm presently trades close to its InvestingPro Honest Worth, sustaining a strong liquidity place with a present ratio of two.69 and exhibiting robust income development of 32% year-over-year. InvestingPro subscribers can entry 6 extra key insights about Tempus AI’s monetary well being and market place.

In different current information, Tempus AI has skilled important adjustments in its inventory worth targets following its newest earnings report and strategic acquisition of genetics agency Ambry. Piper Sandler raised its worth goal from $40 to $70, sustaining a Impartial ranking. Stifel downgraded the inventory from Purchase to Maintain, however elevated the worth goal to $65. Needham raised its inventory worth goal to $56, holding its Purchase ranking.

Tempus AI’s acquisition of Ambry Genetics is considered as a key strategic transfer, doubtlessly providing rapid genomics capabilities and future alternatives in information and purposes. The corporate has additionally partnered with Avacta Therapeutics to advance oncology drug growth utilizing AI, granting Avacta entry to Tempus’s complete multimodal datasets.

Additional, Tempus AI’s Tempus ECG-AF machine, which makes use of synthetic intelligence to determine sufferers at larger danger of atrial fibrillation/flutter, not too long ago obtained FDA clearance. These are among the many current developments surrounding Tempus AI.

This text was generated with the help of AI and reviewed by an editor. For extra info see our T&C.

admin

Share
Published by
admin

Recent Posts

Additional Ideas on Commerce Balances

I lately got here throughout two fascinating articles that bought me fascinated about commerce balances.…

48 minutes ago

Your Seat Room Exceeds Your Allowable Freedom

Fittingly sufficient after writing an prolonged assessment a few ebook concerning the pitfalls of guidelines…

2 hours ago

Who Runs the Nation? No one

I’ve observed with growing frequency that numerous commentators on the media speak about who runs…

3 hours ago

Extra Hidden Prices of Tariffs

Since Trump declared a worldwide commerce battle on April 2, American companies have been scrambling…

4 hours ago

Communicate Now or Eternally Maintain Your Peace

For 35 years, I taught economics on the faculty stage. When educating the idea of…

5 hours ago

How a Lawsuit Towards Realtors Went Sideways

On March 15th, 2024, the Chicago-based Nationwide Affiliation of Realtors (NAR) got here ahead with…

6 hours ago